Log on / register
Feedback | Support | My details
Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.
Gu X, André VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW
Mol Neurodegener 2007, 2:8
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.
Wang CE, Tydlacka S, Orr AL, Yang SH, Graham RK, Hayden MR, Li S, Chan AW, Li XJ
Hum Mol Genet 2008 Sep 1, 17:2738-51
 [PubMed Central] [PubMed] [Related articles]
2.
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW
J Neurosci 2008 Jun 11, 28:6182-95
 [PubMed Central] [PubMed] [Related articles]
3.
Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model.
Tang TS, Guo C, Wang H, Chen X, Bezprozvanny I
J Neurosci 2009 Feb 4, 29:1257-66
 [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.